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Introduction
Pancreatic cancer is the eighth most commonly diagnosed
cancer in the developed world and has one of the worst
prognoses of any malignancy with 98% succumbing to
their disease within 5 years. Little is known about the
etiology of the disease despite significant new insights into
the mutation signatures common this disease. Changes in
microelements serum levels are reported in pancreatic
cancer. In the current study we have examined the levels
of Se, Cu, Fe, Zn and Mg in a moderately sized pancreatic
cancer population and compared it to a healthy age-
matched population.
Material and methods
A total of 84 pancreatic cancer patients and 84 aged-
matched healthy controls were enrolled in the study after
providing informed consent. The patients with pancreatic
cancer were enrolled to the study from the Hospital of
the Ministry of Internal Affairs and Administration in
Szczecin, Poland. For each pancreatic cancer patient
included in this study an unaffected individual registered
in International Hereditary Cancer Center, Pomeranian
Medical University of Szczecin, was used as a control.
Each person enrolled in the study donated ~10 ml
EDTA blood for sufficient serum to be isolated and exam-
ined for the elements Se, Cu, Fe, Zn and Mg. The level of
Se, Cu, Fe, Zn and Mg, in the serum was determined by
mass spectrometry Inductively Coupled Plasma Mass
Spectrometry (Elan DRC-e, PerkinElmer).
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Table 1 The correlation between serum Se level and the









Pancreas I 29.87-55.40 37/5 1 -
II 55.90-67.97 31/11 2.62 0.1635
III 68.06-79.20 9/33 27.13 <0.0001
IV 79.36-137.47 7/35 37 <0.0001
Table 2 The correlation between serum Cu level and the





















Table 3 The correlation between serum Fe level and the
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Results
Conclusions
1. There is a very strong correlation between the
level of selenium, copper in serum and the occur-
rence of pancreatic cancers in the Polish population.
2. The Se, Cu level in serum may be a useful diag-
nostic tool of pancreatic cancer.
3. Further investigations are needed to determine if
Se, Cu levels can be used in:
a. differential diagnosis between pancreatic can-
cer (PC) and non-malignant pancreatic lesions
b. monitoring of systemic treatment efficiency in
PC
c. identification of prognostic factors of pancrea-
tic tumors
d. identification of factor of PC causative
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Table 4 The correlation between serum Zn level and the occurrence of pancreatic cancer.
Cancer site Quartile Zn level (µg/l) No. of cancer / controls OR p- value
Pancreas I 306.12-760.79 23/18 1 -
II 765.29-863.96 14/27 2.46 0.0752
III 864.59-995.08 21/21 1.27 0.6620
IV 995.84-1890.96 25/17 0.86 0.8257
Table 5 The correlation between serum Mg level and the occurrence of pancreatic cancer.
Cancer site Quartile Mg level (µg/l) No. of cancer / controls OR p- value
Pancreas I 11964.63-18616.02 25/16 1 -
II 18673.87-20144.41 18/23 1.99 0.1843
III 20274.88-21673.70 17/24 2.20 0.1215
IV 21775.80-30676.08 22/19 1.34 0.6555
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